Literature DB >> 2573401

Lorazepam discontinuation promotes 'inverse agonist' effects of benzodiazepines.

A Schatzki1, F Lopez, D J Greenblatt, R I Shader, L G Miller.   

Abstract

1. The effects of lorazepam discontinuation on responses to benzodiazepine agonists and antagonists were studied in mice. 2. The convulsant dose of pentylenetetrazol was decreased after an acute dose of lorazepam (0.5 mg kg-1) at 4 days after drug discontinuation, compared to 1 or 7 days after discontinuation or to vehicle treatment. 3. The percentage of mice undergoing convulsions after an acute dose of FG 7142 (40 mg kg-1) was increased at 4 days after lorazepam discontinuation, compared to 1 or 7 days after discontinuation or to vehicle treatment. 4. After an acute dose (0.5 mg kg-1), lorazepam concentrations in cortex tended to be greater in lorazepam-treated compared to vehicle-treated mice at 4 days after discontinuation compared to 1 and 7 days. 5. These data indicate a shift toward reduced agonist sensitivity and increased inverse agonist sensitivity in mice 4 days after lorazepam discontinuation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573401      PMCID: PMC1854718          DOI: 10.1111/j.1476-5381.1989.tb12617.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor.

Authors:  H J Little; D J Nutt; S C Taylor
Journal:  Brain Res Bull       Date:  1987-09       Impact factor: 4.077

Review 2.  Drug therapy. Current status of benzodiazepines.

Authors:  D J Greenblatt; R I Shader; D R Abernethy
Journal:  N Engl J Med       Date:  1983-08-18       Impact factor: 91.245

Review 3.  Abuse liability of benzodiazepines.

Authors:  J H Woods; J L Katz; G Winger
Journal:  Pharmacol Rev       Date:  1987-12       Impact factor: 25.468

4.  Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance.

Authors:  S E File
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 5.  Benzodiazepine dependence. A review of the evidence.

Authors:  R T Owen; P Tyrer
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

6.  Chronic clonazepam administration induces benzodiazepine receptor subsensitivity.

Authors:  J N Crawley; P J Marangos; J Stivers; F K Goodwin
Journal:  Neuropharmacology       Date:  1982-01       Impact factor: 5.250

7.  Kinetics, brain uptake, and receptor binding characteristics of flurazepam and its metabolites.

Authors:  L G Miller; D J Greenblatt; D R Abernethy; H Friedman; M D Luu; S M Paul; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function.

Authors:  L G Miller; D J Greenblatt; J G Barnhill; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

Review 9.  Benzodiazepine withdrawal: overview and implications for the treatment of anxiety.

Authors:  P P Roy-Byrne; D Hommer
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

10.  Optimizing the pentetrazol infusion test for seizure threshold measurement.

Authors:  D J Nutt; S C Taylor; H J Little
Journal:  J Pharm Pharmacol       Date:  1986-09       Impact factor: 3.765

View more
  4 in total

1.  Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.

Authors:  J J Byrnes; L G Miller; D J Greenblatt; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Effect of peripheral administration of cinnarizine and verapamil on the abstinence syndrome in diazepam-dependent rats.

Authors:  Y Chugh; N Saha; A Sankaranarayanan; P L Sharma
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena.

Authors:  S E File; P K Hitchcott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Similar effects of ethanol and flumazenil on acquisition of a shuttle-box avoidance response during withdrawal from chronic ethanol treatment.

Authors:  H E Criswell; G R Breese
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.